|By PR Newswire||
|December 31, 2012 07:01 AM EST||
NEW YORK, Dec. 31, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
China, abundant in heparin raw materials, has become one of the world's largest heparin API producers and exporters, owning to the quality of heparin API having won international recognition gradually. Due to the euro debt crisis, the global market suffered a deep recession. Coupled that the heparin export standard has lifted, China's export volume of heparin API was no more than 105.2 tons in 2011, approximating 14.6 trillion units (measured by 140IU/mg), with the proportion of around 45.9% in the global demand during the same period.
Leading heparin API suppliers worldwide include Shenzhen Hepalink Pharmaceutical, Changzhou Qianhong Bio-Pharma, Yantai Dongcheng Biochemicals and Nanjing King-Friend Biochemical Pharmaceutical, which have ranked top 4 industrial players by export for several years in a row, with the combined export value making up more than 70% of China's total export value of heparin. There is no distinct change in terms of the export pattern. However, the export prices of China's top 10 heparin exporters witnessed a downward mobility in 2011-2012H1. Nevertheless, it was not the same case for Dongying Tiandong Pharmaceutical and Jiangsu Medicine Health Care Article Imp. & Exp. (Group), whose export prices increased by 3.8% and 2.1% year-on-year respectively in Jan.-May, 2012, due to the improved quality of exported products as well as the low cardinal number of exported prices in the preceding year.
Meanwhile, Chinese heparin API flagship enterprises including Shenzhen Hepalink Pharmaceutical, Changzhou Qianhong Bio-Pharma, Yantai Dongcheng Biochemicals, Hebei Changshan Biochemical Pharmaceutical and Nanjing King-Friend Biochemical Pharmaceutical are projected to expand their capacities and improve the heparin industry chains. Among these tycoons, the first four ones have made IPO, while Nanjing King-Friend Biochemical Pharmaceutical is also preparing for IPO by accepting tutoring. According to public information issued by related enterprises, the heparin API capacity of China will increase by more than 18 trillion units by 2014, with the total capacity expected to exceed 30 trillion units, making up over 70% of the global demand.
Although China is a large country with rich heparin API, the downstream production of general heparin preparation and low molecular weight heparin preparation is still at the initial stage. In the high-end low molecular weight heparin preparation market, especially, joint ventures and foreign brands including Sanofi-Aventis, Pfizer and GSK have eroded into the Chinese market. According to China Pharmaceutical Industry Association, imported low molecular weight heparin calcium accounted for more than 60% of the total procurement of such products of representative hospitals in 22 Chinese cities in 2011.
However, with the improvement of R&D and technological strength, the competitiveness of made-in-China low molecular weight heparin preparation market is increasingly enhancing. A case in point is Hebei Changshan Biochemical Pharmaceutical Co., Ltd, the capacity of low molecular weight heparin calcium injection of which soared from 4 million pcs to 10 million pcs in 2011, with the sales increased by 68.4% year-on-year to RMB86.93 million, compared to the sales of RMB117 million in 2012H1, a year-on-year rise of 237.6%.
Table of Contents
1. Profile of Heparin Industry
1.1 Definition & Classification
1.2 Industry Chain
2. Operating Environment of Chinese Heparin Industry
2.1 Entry Barriers
2.1.2 Technical Requirements
2.1.3 Capital Barrier
2.2 Supply and Demand in Global Market
2.3 Competition in Global Market
2.4 Global Market Forecast
3. Development of Heparin API Industry in China
3.1 Market Status Quo
3.2 Market Supply and Demand
3.3 Competitive Landscape
3.4 Import & Export
3.5 Development Outlook & Forecast
4. Development of Heparin Preparation Industry in China
4.1 Market Size
4.2 Competition Pattern
4.3 Market Segments
4.3.1 Low Molecular Weight Heparin Preparation
4.3.2 General Heparin Preparation
4.4 Development Outlook & Forecast
5. Key Chinese Heparin Manufacturers
5.1 Shenzhen Hepalink Pharmaceutical Co., Ltd
5.1.3 Revenue Structure
5.1.4 Gross Margin
5.1.5 R&D and Investment
5.1.6 Clients and Suppliers
5.2 Changzhou Qianhong Bio-Pharma Co., Ltd
5.2.3 Revenue Structure
5.2.4 Gross Margin
5.2.5 R&D and Investment
5.2.6 Clients and Suppliers
5.2.7 Heparin Business
5.3 Yantai Dongcheng Biochemicals Co., Ltd
5.3.3 Revenue Structure
5.3.4 Gross Margin
5.3.5 R&D and Investment
5.3.6 Clients and Suppliers
5.3.7 Heparin Business
5.4 Hebei Changshan Biochemical Pharmaceutical Co., Ltd
5.4.3 Revenue Structure
5.4.4 Gross Margin
5.4.5 R&D and Investment
5.4.6 Clients and Suppliers
5.5 Tianjin Chase Sun Pharmaceutical Co., Ltd
5.5.3 Revenue Structure
5.5.4 Gross Margin
5.5.5 R&D and Investment
5.5.6 Clients and Suppliers
5.5.7 Heparin Business
5.6 Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
5.6.2 Operation and Prospects
5.7 Wanbang Biopharmaceuticals
5.7.2 Operation and Prospects
Application of Heparin Preparations
Heparin Industry Chain
Difference between Heparin Sodium API and Heparin Standardized Requirements
Heparin Preparation Market Scale and YoY Growth Worldwide, 2006-2011
Performance: Low Molecular Weight Heparin Preparation vs. General Heparin Preparation
Global Heparin Preparation Distribution by Region, 2011
Heparin API Demand and YoY Growth Worldwide, 2007-2011
Sales of Enoxaparin Worldwide by Product, 2010-2012
Regulatory Exclusivity of Lovenox, as of late 2011
Global Heparin Preparation Market Scale, 2011-2014E
Global Heparin API Demand, 2011-2014E
Gross Margin of Major Heparin API Manufacturers in China, 2008-2012
Capacity of Crude Heparin in China, 2009-2011
Average Export Price of Heparin and Heparinate, 2008-2012
Capacity of Major Heparin API Manufacturers in China, as of June 2012
Export Volume and Export Value of Heparin and Heparinate in China, 2008-2012
Export Price of Heparin and Heparinate in China, 2008-2012
Top 10 Export Destinations of Heparin and Heparinate in China by Value, 2011-2012
Top 10 Heparin and Heparinate Enterprises in China by Export Value, 2011
Export Volume and Export Value of Heparin and Heparinate in China, Jan.-May, 2012
Import Volume, Import Value and Unite Price of Heparin and Heparinate in China, 2008-2011
Planned / Ongoing Heparin Sodium API Projects in China, as of June 2012
Heparin Preparation Market Scale and YoY Growth of China, 2007-2011
Market Share of Heparin Preparation Products in China, 2011
Main Manufacturers of Heparin Sodium Injection Solution and Heparin Calcium Injection Solution in China
Manufacturers of Low-molecular Heparin Sodium Preparations and Low-molecular Heparin Calcium Preparations
China Low Molecular Weight Heparin Preparation Market Scale, 2009-2011
Purchase Value of Low Molecular Weight Heparin Calcium of Chinese Representative Hospitals, 2010-2011
Low Molecular Weight Heparin Preparation Imported Value of Representative Hospitals in 22 Chinese Cities, 2010-2011
Competition Pattern of China Low Molecular Weight Heparin Calcium Market, 2009
Competition Pattern of China Low Molecular Weight Heparin Sodium Market, 2009
China Heparin Preparation Market Scale and YoY Growth, 2011-2014
Assets and Net Income of Holding Subsidiaries under Hepalink, 2012H1
Revenue and Profit of Hepalink, 2008-2012
Revenue of Hepalink by Product, 2008-2012
Revenue of Hepalink by Region, 2008-2012
Gross Margin of Hepalink by Product, 2008-2012
R&D Investment and Proportion in Revenue of Hepalink, 2009-2011
Revenue of Hepalink from the Top 5 Clients and Proportion, 2008-2012
Revenue and Operating Income of Hepalink, 2011-2014E
Assets, Revenue and Net Income of Subsidiaries under Qianhong Bio-Pharma, 2012H1
Revenue and Profit of Qianhong Bio-Pharma, 2008-2012
Revenue of Qianhong Bio-Pharma by Product, 2008-2012
Revenue of Qianhong Bio-Pharma by Region, 2008-2012
Gross Margin of Qianhong Bio-Pharma by Product, 2008-2012
R&D Investment and Proportion in Revenue of Qianhong Bio-Pharma, 2009-2011
Scheduling of Planned/Ongoing Projects of Qianhong Bio-Pharma, as of June 2012
Top 5 Clients, Revenue Contribution and Proportion of Qianhong Bio-Pharma, 2011
Purchase Value of Qianhong Bio-Pharma's Top 5 Suppliers and Revenue Contribution of Qianhong Bio-Pharma's Top 5 Clients, 2009-2012
Revenue and Gross Margin from Heparin Business of Qianhong Bio-Pharma, 2008-2012
Revenue and Operating Income of Qianhong Bio-Pharma, 2011-2014
Assets, Revenue and Net Income of Subsidiaries under Dongcheng Biochemicals, 2012H1
Revenue and Profit of Dongcheng Biochemicals, 2008-2012
Revenue of Dongcheng Biochemicals by Product, 2008-2012
Revenue of Dongcheng Biochemicals by Region, 2008-2012
Gross Margin of Dongcheng Biochemicals by Product, 2008-2012
R&D Investment and Proportion in Revenue of Dongcheng Biochemicals, 2008-2012
Revenue and Gross Margin from Heparin Sodium API Business of Dongcheng Biochemicals, 2008-2012
Heparin Sodium API Price of Dongcheng Biochemicals, 2009-2011
Revenue Contribution of Dongcheng Biochemicals' Top 5 Heparin Sodium API Clients, 2009-2011
Scheduling of Heparin Sodium API Projects of Dongcheng Biochemicals, 2013-2015E
Revenue and Profit of Dongcheng Biochemicals, 2011-2014E
Revenue and Profit of Hebei Changshan Biochemical Pharmaceutical, 2008-2012
Revenue of Hebei Changshan Biochemical Pharmaceutical by Product, 2008-2012
Revenue of Hebei Changshan Biochemical Pharmaceutical by Region, 2008-2012
Gross Margin of Hebei Changshan Biochemical Pharmaceutical by Product, 2008-2012
R&D Investment and Proportion in Revenue of Hebei Changshan Biochemical Pharmaceutical, 2009-2011
Product Research Scheduling of Hebei Changshan Biochemical Pharmaceutical, as of late 2011
Name List, Revenue Contribution and Proportion of Top 5 Clients of Hebei Changshan Biochemical Pharmaceutical, 2011
Heparin Product Certificates Won by Hebei Changshan Biochemical Pharmaceutical Overseas, as of late 2011
Revenue and Profit of Hebei Changshan Biochemical Pharmaceutical, 2011-2014E
Revenue and Profit of Tianjin Chase Sun Pharmaceutical, 2008-2012
Revenue of Tianjin Chase Sun Pharmaceutical by Product, 2008-2012
Revenue of Tianjin Chase Sun Pharmaceutical by Region, 2008-2012
Gross Margin of Tianjin Chase Sun Pharmaceutical by Product, 2008-2012
R&D Investment and Proportion in Revenue of Tianjin Chase Sun Pharmaceutical, 2009-2011
Name List, Revenue Contribution and Proportion of Top 5 Clients of Tianjin Chase Sun Pharmaceutical, 2011
Name List, Purchase Value and Proportion of Top 5 Suppliers of Tianjin Chase Sun Pharmaceutical, 2011
Revenue and Gross Margin from Heparin Business of Tianjin Chase Sun Pharmaceutical, 2008-2012
Revenue and Operating Income of Tianjin Chase Sun Pharmaceutical, 2011-2014
Assets and Net Income of Wanbang Biopharmaceuticals, 2008-2011
Contact Nicolas: [email protected]
Intl: +1 805-652-2626
Almost everyone sees the potential of Internet of Things but how can businesses truly unlock that potential. The key will be in the ability to discover business insight in the midst of an ocean of Big Data generated from billions of embedded devices via Systems of Discover. Businesses will also need to ensure that they can sustain that insight by leveraging the cloud for global reach, scale and elasticity.
Jan. 26, 2015 01:00 PM EST Reads: 5,590
DevOps Summit 2015 New York, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that it is now accepting Keynote Proposals. The widespread success of cloud computing is driving the DevOps revolution in enterprise IT. Now as never before, development teams must communicate and collaborate in a dynamic, 24/7/365 environment. There is no time to wait for long development cycles that produce software that is obsolete at launch. DevOps may be disruptive, but it is essential.
Jan. 26, 2015 12:15 PM EST Reads: 3,717
The 3rd International Internet of @ThingsExpo, co-located with the 16th International Cloud Expo - to be held June 9-11, 2015, at the Javits Center in New York City, NY - announces that its Call for Papers is now open. The Internet of Things (IoT) is the biggest idea since the creation of the Worldwide Web more than 20 years ago.
Jan. 26, 2015 12:00 PM EST Reads: 9,773
SYS-CON Media announced that Cisco, a worldwide leader in IT that helps companies seize the opportunities of tomorrow, has launched a new ad campaign in Cloud Computing Journal. The ad campaign, a webcast titled 'Is Your Data Center Ready for the Application Economy?', focuses on the latest data center networking technologies, including SDN or ACI, and how customers are using SDN and ACI in their organizations to achieve business agility. The Cisco webcast is available on-demand.
Jan. 26, 2015 12:00 PM EST Reads: 2,095
"BSQUARE is in the business of selling software solutions for smart connected devices. It's obvious that IoT has moved from being a technology to being a fundamental part of business, and in the last 18 months people have said let's figure out how to do it and let's put some focus on it, " explained Dave Wagstaff, VP & Chief Architect, at BSQUARE Corporation, in this SYS-CON.tv interview at @ThingsExpo, held Nov 4-6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Jan. 26, 2015 11:30 AM EST Reads: 3,357
Building low-cost wearable devices can enhance the quality of our lives. In his session at Internet of @ThingsExpo, Sai Yamanoor, Embedded Software Engineer at Altschool, provided an example of putting together a small keychain within a $50 budget that educates the user about the air quality in their surroundings. He also provided examples such as building a wearable device that provides transit or recreational information. He then reviewed the resources available to build wearable devices at home including open source hardware, the raw materials required and the options available to power s...
Jan. 26, 2015 11:00 AM EST Reads: 3,226
“The age of the Internet of Things is upon us,” stated Thomas Svensson, senior vice-president and general manager EMEA, ThingWorx, “and working with forward-thinking companies, such as Elisa, enables us to deploy our leading technology so that customers can profit from complete, end-to-end solutions.” ThingWorx, a PTC® (Nasdaq: PTC) business and Internet of Things (IoT) platform provider, announced on Monday that Elisa, Finnish provider of mobile and fixed broadband subscriptions, will deploy ThingWorx® platform technology to enable a new Elisa IoT service in Finland and Estonia.
Jan. 26, 2015 11:00 AM EST Reads: 2,274
Advanced Persistent Threats (APTs) are increasing at an unprecedented rate. The threat landscape of today is drastically different than just a few years ago. Attacks are much more organized and sophisticated. They are harder to detect and even harder to anticipate. In the foreseeable future it's going to get a whole lot harder. Everything you know today will change. Keeping up with this changing landscape is already a daunting task. Your organization needs to use the latest tools, methods and expertise to guard against those threats. But will that be enough? In the foreseeable future attacks w...
Jan. 26, 2015 11:00 AM EST Reads: 4,485
As enterprises move to all-IP networks and cloud-based applications, communications service providers (CSPs) – facing increased competition from over-the-top providers delivering content via the Internet and independently of CSPs – must be able to offer seamless cloud-based communication and collaboration solutions that can scale for small, midsize, and large enterprises, as well as public sector organizations, in order to keep and grow market share. The latest version of Oracle Communications Unified Communications Suite gives CSPs the capability to do just that. In addition, its integration ...
Jan. 26, 2015 11:00 AM EST Reads: 4,323
From telemedicine to smart cars, digital homes and industrial monitoring, the explosive growth of IoT has created exciting new business opportunities for real time calls and messaging. In his session at @ThingsExpo, Ivelin Ivanov, CEO and Co-Founder of Telestax, shared some of the new revenue sources that IoT created for Restcomm – the open source telephony platform from Telestax. Ivelin Ivanov is a technology entrepreneur who founded Mobicents, an Open Source VoIP Platform, to help create, deploy, and manage applications integrating voice, video and data. He is the co-founder of TeleStax, a...
Jan. 26, 2015 10:45 AM EST Reads: 4,760
Today’s enterprise is being driven by disruptive competitive and human capital requirements to provide enterprise application access through not only desktops, but also mobile devices. To retrofit existing programs across all these devices using traditional programming methods is very costly and time consuming – often prohibitively so. In his session at @ThingsExpo, Jesse Shiah, CEO, President, and Co-Founder of AgilePoint Inc., discussed how you can create applications that run on all mobile devices as well as laptops and desktops using a visual drag-and-drop application – and eForms-buildi...
Jan. 26, 2015 10:45 AM EST Reads: 3,892
We certainly live in interesting technological times. And no more interesting than the current competing IoT standards for connectivity. Various standards bodies, approaches, and ecosystems are vying for mindshare and positioning for a competitive edge. It is clear that when the dust settles, we will have new protocols, evolved protocols, that will change the way we interact with devices and infrastructure. We will also have evolved web protocols, like HTTP/2, that will be changing the very core of our infrastructures. At the same time, we have old approaches made new again like micro-services...
Jan. 26, 2015 10:30 AM EST Reads: 3,697
ARMONK, N.Y., Nov. 20, 2014 /PRNewswire/ -- IBM (NYSE: IBM) today announced that it is bringing a greater level of control, security and flexibility to cloud-based application development and delivery with a single-tenant version of Bluemix, IBM's platform-as-a-service. The new platform enables developers to build ap...
Jan. 26, 2015 10:30 AM EST Reads: 4,295
Disruptive macro trends in technology are impacting and dramatically changing the "art of the possible" relative to supply chain management practices through the innovative use of IoT, cloud, machine learning and Big Data to enable connected ecosystems of engagement. Enterprise informatics can now move beyond point solutions that merely monitor the past and implement integrated enterprise fabrics that enable end-to-end supply chain visibility to improve customer service delivery and optimize supplier management. Learn about enterprise architecture strategies for designing connected systems tha...
Jan. 26, 2015 10:00 AM EST Reads: 4,610
SYS-CON Events announced today that CodeFutures, a leading supplier of database performance tools, has been named a “Sponsor” of SYS-CON's 16th International Cloud Expo®, which will take place on June 9–11, 2015, at the Javits Center in New York, NY. CodeFutures is an independent software vendor focused on providing tools that deliver database performance tools that increase productivity during database development and increase database performance and scalability during production.
Jan. 26, 2015 10:00 AM EST Reads: 2,569
The Internet of Things is a misnomer. That implies that everything is on the Internet, and that simply should not be - especially for things that are blurring the line between medical devices that stimulate like a pacemaker and quantified self-sensors like a pedometer or pulse tracker. The mesh of things that we manage must be segmented into zones of trust for sensing data, transmitting data, receiving command and control administrative changes, and peer-to-peer mesh messaging. In his session at @ThingsExpo, Ryan Bagnulo, Solution Architect / Software Engineer at SOA Software, focused on desi...
Jan. 26, 2015 10:00 AM EST Reads: 3,528
"For over 25 years we have been working with a lot of enterprise customers and we have seen how companies create applications. And now that we have moved to cloud computing, mobile, social and the Internet of Things, we see that the market needs a new way of creating applications," stated Jesse Shiah, CEO, President and Co-Founder of AgilePoint Inc., in this SYS-CON.tv interview at 15th Cloud Expo, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
Jan. 26, 2015 09:30 AM EST Reads: 3,344
Things are being built upon cloud foundations to transform organizations. This CEO Power Panel at 15th Cloud Expo, moderated by Roger Strukhoff, Cloud Expo and @ThingsExpo conference chair, addressed the big issues involving these technologies and, more important, the results they will achieve. Rodney Rogers, chairman and CEO of Virtustream; Brendan O'Brien, co-founder of Aria Systems, Bart Copeland, president and CEO of ActiveState Software; Jim Cowie, chief scientist at Dyn; Dave Wagstaff, VP and chief architect at BSQUARE Corporation; Seth Proctor, CTO of NuoDB, Inc.; and Andris Gailitis, C...
Jan. 26, 2015 09:00 AM EST Reads: 3,834
Recurring revenue models are great for driving new business in every market sector, but they are complex and need to be effectively managed to maximize profits. How you handle the range of options for pricing, co-terming and proration will ultimately determine the fate of your bottom line. In his session at 15th Cloud Expo, Brendan O'Brien, Co-founder at Aria Systems, session examined: How time impacts recurring revenue How to effectively handle customer plan changes The range of pricing and packaging options to consider
Jan. 26, 2015 09:00 AM EST Reads: 3,980
The Industrial Internet revolution is now underway, enabled by connected machines and billions of devices that communicate and collaborate. The massive amounts of Big Data requiring real-time analysis is flooding legacy IT systems and giving way to cloud environments that can handle the unpredictable workloads. Yet many barriers remain until we can fully realize the opportunities and benefits from the convergence of machines and devices with Big Data and the cloud, including interoperability, data security and privacy.
Jan. 26, 2015 07:45 AM EST Reads: 3,754